A GC-MS-Based Metabolomics Investigation of the Protective Effect of Liu-Wei-Di-Huang-Wan in Type 2 Diabetes Mellitus Mice

Table 1

FBG and urinary ACR values of different groups before and after treatment.

Groups	FBG before treatment (mmol/L)	FBG after treatment (mmol/L)	Urinary ACR before treatment (mg/g)	Urinary ACR after treatment (mg/g)
MKR group	14.99 ± 2.022	13.95 ± 2.772	154.4 ± 6.976	185.2 ± 11.04
Model control group	7.855 ± 0.723	8.218 ± 0.9347	62.24 ± 6.201	83.04 ± 6.05
Liu-Wei-Di-Huang group	14.12 ± 1.656	9.509 ± 0.5752	150.8 ± 7.368	115.8 ± 6.968
Western medicine group	14.12 ± 1.224	8.718 ± 0.5307	151.2 ± 6.319	112.4 ± 7.232
Normal control group	5.145 ± 0.3417	5.209 ± 0.7355	5.382 ± 1.369	5.591 ± 1.436